PortfoliosLab logoPortfoliosLab logo
BPLEX vs. INSM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BPLEX vs. INSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Partners Long/Short Equity Fund (BPLEX) and Insmed Incorporated (INSM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BPLEX achieves a 11.01% return, which is significantly higher than INSM's -45.89% return. Over the past 10 years, BPLEX has underperformed INSM with an annualized return of 13.27%, while INSM has yielded a comparatively higher 24.09% annualized return.


BPLEX

1D
-0.51%
1M
0.09%
YTD
11.01%
6M
14.13%
1Y
29.37%
3Y*
36.31%
5Y*
23.80%
10Y*
13.27%

INSM

1D
-0.05%
1M
-7.08%
YTD
-45.89%
6M
-52.09%
1Y
27.91%
3Y*
68.17%
5Y*
27.84%
10Y*
24.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BPLEX vs. INSM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BPLEX
Boston Partners Long/Short Equity Fund
11.01%27.87%56.97%14.93%6.95%31.73%-5.82%8.97%-15.70%2.54%
INSM
Insmed Incorporated
-45.89%152.09%122.78%55.11%-26.65%-18.17%39.41%82.01%-57.92%135.68%

Correlation

The correlation between BPLEX and INSM is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jun 1, 2000

0.13

The correlation between BPLEX and INSM shifts across timeframes, from 0.04 (1 year) to 0.24 (10 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BPLEX vs. INSM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BPLEX
BPLEX Risk / Return Rank: 9393
Overall Rank
BPLEX Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
BPLEX Sortino Ratio Rank: 9494
Sortino Ratio Rank
BPLEX Omega Ratio Rank: 8585
Omega Ratio Rank
BPLEX Calmar Ratio Rank: 9696
Calmar Ratio Rank
BPLEX Martin Ratio Rank: 9595
Martin Ratio Rank

INSM
INSM Risk / Return Rank: 5757
Overall Rank
INSM Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
INSM Sortino Ratio Rank: 5757
Sortino Ratio Rank
INSM Omega Ratio Rank: 6262
Omega Ratio Rank
INSM Calmar Ratio Rank: 5454
Calmar Ratio Rank
INSM Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BPLEX vs. INSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Partners Long/Short Equity Fund (BPLEX) and Insmed Incorporated (INSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BPLEXINSMDifference
Sharpe ratioReturn per unit of total volatility

+2.58

Sortino ratioReturn per unit of downside risk

+3.67

Omega ratioGain probability vs. loss probability

1.56

1.17

+0.39

Calmar ratioReturn relative to maximum drawdown

6.11

0.51

+5.61

Martin ratioReturn relative to average drawdown

22.01

1.23

+20.77

BPLEX vs. INSM - Sharpe Ratio Comparison

The current BPLEX Sharpe Ratio is 3.05, which is higher than the INSM Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of BPLEX and INSM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BPLEXINSMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.05

0.47

+2.58

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.63

0.38

+0.24

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

0.31

+0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

0.55

-0.02

+0.58

Drawdowns

BPLEX vs. INSM - Drawdown Comparison

The maximum BPLEX drawdown since its inception was -43.47%, smaller than the maximum INSM drawdown of -98.65%. Use the drawdown chart below to compare losses from any high point for BPLEX and INSM.


Loading charts...

Drawdown Indicators


BPLEXINSMDifference

Max Drawdown

Largest peak-to-trough decline

-43.47%

-98.65%

+55.18%

Max Drawdown (1Y)

Largest decline over 1 year

-5.23%

-55.46%

+50.23%

Max Drawdown (3Y)

Largest decline over 3 years

-28.78%

-55.46%

+26.68%

Max Drawdown (5Y)

Largest decline over 5 years

-28.78%

-55.46%

+26.68%

Max Drawdown (10Y)

Largest decline over 10 years

-37.65%

-64.84%

+27.19%

Current Drawdown

Current decline from peak

-0.51%

-55.46%

+54.95%

Average Drawdown

Average peak-to-trough decline

-6.61%

-86.11%

+79.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.45%

22.66%

-21.21%

Volatility

BPLEX vs. INSM - Volatility Comparison

The current volatility for Boston Partners Long/Short Equity Fund (BPLEX) is 3.82%, while Insmed Incorporated (INSM) has a volatility of 18.58%. This indicates that BPLEX experiences smaller price fluctuations and is considered to be less risky than INSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BPLEXINSMDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.82%

18.58%

-14.76%

Volatility (6M)

Calculated over the trailing 6-month period

8.28%

45.00%

-36.72%

Volatility (1Y)

Calculated over the trailing 1-year period

10.49%

59.24%

-48.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.91%

72.76%

-34.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.28%

78.47%

-49.19%

Dividends

BPLEX vs. INSM - Dividend Comparison

BPLEX's dividend yield for the trailing twelve months is around 9.86%, while INSM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BPLEX
Boston Partners Long/Short Equity Fund
9.86%10.94%58.72%28.35%15.19%5.11%44.84%11.33%9.69%0.83%0.00%9.91%
INSM
Insmed Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


BPLEX and INSM have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INSM has higher volatility (18.58%) compared to BPLEX (3.82%). In terms of maximum drawdown, BPLEX dropped -43.47% vs INSM's -98.65%.

BPLEX currently has the higher Sharpe Ratio (3.05 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BPLEX and INSM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer